Appropriate Chemotherapeutics for Advanced Periodontal Therapies
Gregory E. Oxford DDS, MS, PhD
Not all patients that need or require surgical periodontal care are candidates for this form of therapy. A variety of factors preclude them from receiving or pursuing surgery to correct their problems. This population of patients may benefit from a variety of chemotherapeutic pharmacologic agents currently available to affect host modulation and address their disease. This program will explore the rationale and appropriate usage of pharmacologic agents used as adjuncts to traditional modes of periodontal therapy as well as DNA culturing to assist your selection of medications.
Participants will :
“Appropriate Chemotherapeutics for Advanced Periodontal Therapies” is co-sponsored by Tribune Group GmbH. Tribune Group GmbH is a recognized ADA CERP and AGD PACE provider.
At the end of the webinar, after passing the C.E. Quiz, you will be able to download your ADA CERP and AGD PACE C.E. Certificates.